PHARMACEUTICAL COMPOSITIONS CONTAINING DEFAMINE RECEPTOR LIGANDS, AND TREATMENT METHODS USING DOPAMINE RECEPTORS

摘要

The present invention relates to pharmaceutical compositions containing dopamine receptor ligands and selective serotonin reuptake inhibitors, and methods of treating diseases such as schizophrenia, major depressive disorder and bipolar depression using a combination of dopamine receptor ligands and selective serotonin reuptake inhibitors. The present invention also relates to methods for treating depression using dopamine receptor ligands.